Skip to main content
Fig. 6 | Renal Replacement Therapy

Fig. 6

From: Clinical characteristics of renal transplant recipients who developed de novo donor-specific antigen in Kyoto University Hospital: a case series

Fig. 6

Clinical course and change in serum creatinine level in case #4. Case 4 is a 49-year-old woman with an unknown primary disease who received an ABO-compatible transplant with her husband as the donor. CyA: cyclosporin A; PSL: prednisolone; MMF: mycophenolate mofetil; cABMR: chronic antibody-mediated rejection; DSA: donor-specific antigen; PE: plasma exchange; IVIG: intravenous immunoglobulin; HD: hemodialysis

Back to article page